These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24603568)

  • 1. Cystic Fibrosis Trust's clarification of Cohen and Raftery's article on cystic fibrosis drug development.
    Owen E
    BMJ; 2014 Mar; 348():g1849. PubMed ID: 24603568
    [No Abstract]   [Full Text] [Related]  

  • 2. A new model for drug development using a multi-stakeholder consortium.
    Hall AK
    BMJ; 2014 Mar; 348():g1850. PubMed ID: 24603569
    [No Abstract]   [Full Text] [Related]  

  • 3. Paying twice: questions over high cost of cystic fibrosis drug developed with charitable funding.
    Cohen D; Raftery J
    BMJ; 2014 Feb; 348():g1445. PubMed ID: 24523379
    [No Abstract]   [Full Text] [Related]  

  • 4. Pricing for orphan drugs: will the market bear what society cannot?
    O'Sullivan BP; Orenstein DM; Milla CE
    JAMA; 2013 Oct; 310(13):1343-4. PubMed ID: 24084916
    [No Abstract]   [Full Text] [Related]  

  • 5. Orkambi's Slick Unveiling Puts Insurers in a Bind.
    Silverman E
    Manag Care; 2015 Aug; 24(8):16-7. PubMed ID: 26399136
    [No Abstract]   [Full Text] [Related]  

  • 6. Foundation receives $3.3-billion windfall for Kalydeco.
    Senior M
    Nat Biotechnol; 2015 Jan; 33(1):8-9. PubMed ID: 25574617
    [No Abstract]   [Full Text] [Related]  

  • 7. Promising gene therapies pose million-dollar conundrum.
    Check Hayden E
    Nature; 2016 Jun; 534(7607):305-6. PubMed ID: 27306167
    [No Abstract]   [Full Text] [Related]  

  • 8. Cystic fibrosis drug is not cost effective, says NICE.
    Gulland A
    BMJ; 2016 Jun; 353():i3409. PubMed ID: 27325384
    [No Abstract]   [Full Text] [Related]  

  • 9. Settlement reached over medicaid coverage of cystic fibrosis drug: Arkansas federal court case highlights medical necessity, high cost of targeted therapies.
    Am J Med Genet A; 2015 Apr; 167A(4):viii-ix. PubMed ID: 25820402
    [No Abstract]   [Full Text] [Related]  

  • 10. Personalized medicine. New cystic fibrosis drug offers hope, at a price.
    Kaiser J
    Science; 2012 Feb; 335(6069):645. PubMed ID: 22323790
    [No Abstract]   [Full Text] [Related]  

  • 11. Precision Medicine: At What Price?
    Ferkol T; Quinton P
    Am J Respir Crit Care Med; 2015 Sep; 192(6):658-9. PubMed ID: 26207804
    [No Abstract]   [Full Text] [Related]  

  • 12. Lumacaftor/ivacaftor (Orkambi) for cystic fibrosis.
    Med Lett Drugs Ther; 2016 Mar; 58(1491):41-2. PubMed ID: 27027688
    [No Abstract]   [Full Text] [Related]  

  • 13. New cystic fibrosis drug paves the way for orphan diseases.
    Cooney D
    Lancet Respir Med; 2013 Apr; 1(2):104. PubMed ID: 24429084
    [No Abstract]   [Full Text] [Related]  

  • 14. Cystic fibrosis drug Vertex's latest triumph.
    Ledford H
    Nat Biotechnol; 2012 Mar; 30(3):201-2. PubMed ID: 22398597
    [No Abstract]   [Full Text] [Related]  

  • 15. Excitement mounts for first disease-modifying cystic fibrosis drugs.
    Opar A
    Nat Rev Drug Discov; 2011 Jul; 10(7):479-80. PubMed ID: 21720393
    [No Abstract]   [Full Text] [Related]  

  • 16. Healthcare resource utilization associated with ivacaftor use in patients with cystic fibrosis.
    Suthoff ED; Bonafede M; Limone B; O'Callaghan L; Sawicki GS; Wagener JS
    J Med Econ; 2016 Sep; 19(9):845-51. PubMed ID: 27074519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sweat chloride is not a useful marker of clinical response to Ivacaftor.
    Barry PJ; Jones AM; Webb AK; Horsley AR
    Thorax; 2014 Jun; 69(6):586-7. PubMed ID: 24258833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orphan cystic fibrosis drugs find sister diseases.
    Dolgin E
    Nat Med; 2011 Apr; 17(4):397. PubMed ID: 21475214
    [No Abstract]   [Full Text] [Related]  

  • 19. Cystic fibrosis in an era of genomically guided therapy.
    Barrett PM; Alagely A; Topol EJ
    Hum Mol Genet; 2012 Oct; 21(R1):R66-71. PubMed ID: 22914736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forecasting the Long-Term Clinical and Economic Outcomes of Lumacaftor/Ivacaftor in Cystic Fibrosis Patients with Homozygous phe508del Mutation.
    Dilokthornsakul P; Patidar M; Campbell JD
    Value Health; 2017 Dec; 20(10):1329-1335. PubMed ID: 29241892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.